Low risk does not mean absence of disease: from the cardiovascular score to atherosclerosis demonstrated by imaging
DOI:
https://doi.org/10.63600/8307xv70Keywords:
Cardiovascular risk, PREVENT, SCORE2, Atherosclerosis, Coronary calcium, Primary preventionAbstract
Cardiovascular risk scores are central tools for primary prevention, but they should not be interpreted as diagnostic proof of the absence of atherosclerosis. In young or middle-aged adults, chronological age and the 10-year time horizon may yield low-risk estimates despite significant arterial disease. This discordance becomes clinically relevant when vascular ultrasound, coronary artery calcium scoring, or coronary computed tomography angiography identify an atherosclerotic burden not anticipated by the probabilistic model. We propose integrating estimated risk, clinical-biological modifiers, and targeted vascular imaging to reclassify discordant patients and adjust preventive intensity according to actually demonstrated disease.
References
1. Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, et al. Development and validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) equations. Circulation. 2024;149:430-449.
2. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227-3337.
3. Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099.
4. Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary calcium score and cardiovascular risk. J Am Coll Cardiol. 2018;72:434-447.
5. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459-2472.
